Susan Wendel

About Susan Wendel

Dynamic, strategic, results-driven asset leader with 25+ years of experience in global drug development across all development phases (early development to manufacturing, through launch and life-cycle management). A curious and creative thinker who applies unique thought processes within early and late product development to simultaneously achieve scientific, clinical, regulatory, and business objectives. A globally-minded, innovative leader who uses data, constructive dialog, and a flexible mindset to drive strategy, solve big problems, and implement solutions that deliver outstanding, sustainable value. Quickly establishes credibility as a trusted partner to senior management, peers, and stakeholders while leading and developing a collaborative, fun, and enjoyable atmosphere where multi-disciplinary, multi-site project teams and global initiative teams thrive and produce successful, sustainable results.

Experience

1. Senior Director, Integration Leader

   Johnson & Johnson

   Jun 2024 — Present

   Accountable for the integration of $1.2bn acquisition of NewCo comprised of an atopic derm asset, employees and on-going clinical/development activities• Leading all acquisition activities and actively partner across key stakeholders in TA, A&D, BD and cross-functional partners

Education

• Shippensburg University of Pennsylvania

  BS, Chemistry

• Rutgers University

  Ph.D., Pharmaceutics

Skills

• Pharmaceutical Industry
• Technology Transfer
• Clinical Development
• Drug Development
• Drug Discovery
• Gmp
• Biotechnology
• Fda
• Validation
• Sop
• Life Sciences
• Glp
• Biopharmaceuticals
• Regulatory Affairs
• R&D
• CRO
• Change Control
• Clinical Trials
• Commercialization
• Drug Delivery
• Formulation
• Gcp
• Hplc
• Infectious Diseases
• Lifesciences
• Medical Devices
• Oncology
• Pharmaceutics
• Pharmacology
• R
• Regulatory Submissions
• Ind